Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
Concentration Dependence of 5-Aminosalicylic Acid Pharmacological Actions in Intestinal Mucosa after Oral Administration of a pH-Dependent Formulation | Molecular Pharmaceutics
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art - ScienceDirect
Asacol: Package Insert / Prescribing Information - Drugs.com
The long journey of salicylates in ulcerative colitis: The past and the future - ScienceDirect
Asacol HD: Side Effects, Dosage, Cost, Use, and More
Review article: 5‐aminosalicylate formulations for the treatment of ulcerative colitis – methods of comparing release rates and delivery of 5‐aminosalicylate to the colonic mucosa - LICHTENSTEIN - 2008 - Alimentary Pharmacology & Therapeutics ...
Concentration Dependence of 5-Aminosalicylic Acid Pharmacological Actions in Intestinal Mucosa after Oral Administration of a pH-Dependent Formulation | Molecular Pharmaceutics
A review of the biological and pharmacological activities of mesalazine or 5-aminosalicylic acid (5-ASA): an anti-ulcer and anti-oxidant drug | SpringerLink
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
5-ASA | IBD Clinic
Concentration Dependence of 5-Aminosalicylic Acid Pharmacological Actions in Intestinal Mucosa after Oral Administration of a pH-Dependent Formulation | Molecular Pharmaceutics
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
5-aminosalicylates [TUSOM | Pharmwiki]
Solved 3. What is t he mechanism of action of the mesalamine | Chegg.com
Which 5-ASA? Understanding the choices in ulcerative colitis therapy | Gastrointestinal Nursing
Inflammatory Bowel Disease: Front-line Issues in Diagnosis & Management (Transcript)